Argenx, NL0010832176

Argenx shares head into the open after September 24 market data

Published on 09/25/2026 at 06:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Argenx shares had a dated US market reference while the Nasdaq Composite finished at 26,939.37, up less than 0.1 percent. Today brings scheduled US economic releases.

Fotorealistisches Laborpanorama: Wissenschaftler in weißen Kitteln begutachten leuchtende Antikörper-3D-Modelle auf Bildschirmen, Stahltische mit Laborgeräten im Hintergrund
Argenx NL0010832176 Forscher analysieren im modernen Biopharma-Labor leuchtende Antikörper-Strukturen auf großen Monitoren, Illustration mit AI erstellt.

Argenx stock had a closing reference from the September 24, 2026 US session, while the Nasdaq Composite finished at 26,939.37, up less than 0.1 percent on the same date. The broader market ended mixed as investors monitored oil prices and US bonds.

September 24, 2026 market context

Argenx (ISIN NL0010832176) enters the pre-market recap against a Nasdaq Composite close of 26,939.37 on September 24, 2026. The index change was less than 0.1 percent, providing the quantified market comparison available for the session.

CNBC reported that the Dow slipped about 162 points, or 0.3 percent, while the S&P 500 and Nasdaq Composite finished flat in regular trading on September 24, 2026.

September 25, 2026 outlook

US economic releases scheduled for September 25, 2026 include goods orders excluding defense and aircraft, while Federal Reserve officials are scheduled to speak, according to Investing.com. These rate and economic signals can affect biotechnology valuations through their influence on broader market conditions.

Disclaimer...

en | NL0010832176 | ARGENX | boerse | 70180902 | bgmi